Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.450
+0.050 (3.58%)
Apr 29, 2026, 9:37 AM EDT - Market open
Innate Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 129 | 173 | 166 | 233 | 282 | 400 | |
| Market Cap Growth | -22.59% | 4.71% | -29.08% | -17.19% | -29.50% | 19.60% | |
| Enterprise Value | 116 | 135 | 107 | 180 | 196 | 283 | |
| Last Close Price | 1.40 | 1.75 | 1.84 | 2.80 | 3.73 | 4.56 | |
| PS Ratio | 12.24 | 16.40 | 7.95 | 3.43 | 4.58 | 14.24 | |
| PB Ratio | - | -6.80 | 18.11 | 4.07 | 4.87 | 3.27 | |
| P/TBV Ratio | - | - | 18.11 | 4.10 | 5.02 | 5.56 | |
| EV/Sales Ratio | 10.94 | 12.73 | 5.15 | 2.65 | 3.19 | 10.07 | |
| Debt / Equity Ratio | -1.04 | -1.04 | 3.51 | 0.77 | 0.78 | 0.41 | |
| Net Debt / Equity Ratio | 0.54 | 0.54 | -5.63 | -1.01 | -1.09 | -0.70 | |
| Net Debt / EBITDA Ratio | 0.22 | 0.22 | 0.99 | 6.16 | 4.93 | 1.75 | |
| Net Debt / FCF Ratio | 0.22 | 0.22 | 6.83 | 1.60 | 3.01 | 1.27 | |
| Asset Turnover | 0.10 | 0.10 | 0.14 | 0.33 | 0.25 | 0.09 | |
| Quick Ratio | 1.14 | 1.14 | 2.50 | 3.51 | 3.21 | 1.67 | |
| Current Ratio | 1.27 | 1.27 | 2.60 | 3.73 | 3.38 | 1.73 | |
| Return on Equity (ROE) | - | - | -162.91% | -14.28% | -71.75% | -34.53% | |
| Return on Assets (ROA) | -38.85% | -38.85% | -22.52% | -4.23% | -4.40% | -10.40% | |
| Return on Invested Capital (ROIC) | - | - | - | - | -122.70% | -173.03% | |
| Return on Capital Employed (ROCE) | -207.20% | -207.20% | -66.10% | -9.30% | -10.40% | -25.50% | |
| Earnings Yield | -44.61% | -33.30% | -30.93% | -3.58% | -22.02% | -15.02% | |
| FCF Yield | -47.81% | -35.82% | -4.56% | -15.58% | -7.46% | -16.89% | |
| Buyback Yield / Dilution | -10.54% | -10.54% | -0.74% | -1.02% | -0.12% | -0.77% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.